BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19543515)

  • 1. Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.
    Uhm KO; Lee ES; Lee YM; Park JS; Kim SJ; Kim BS; Kim HS; Park SH
    J Korean Med Sci; 2009 Jun; 24(3):493-7. PubMed ID: 19543515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
    Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
    J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
    Pehlivan M; Sercan Z; Sercan HO
    Leuk Res; 2009 Aug; 33(8):1062-7. PubMed ID: 19118898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia].
    Liu F; Xu RR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):471-3. PubMed ID: 22803425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ID4 promoter methylation in acute myeloid leukemia].
    Xu RR; Liu F; Cui X; Zhang XW; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
    J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of id4 promoter methylation in monitoring AML patients with completely remission].
    Zhao Y; Wang QS; Li HH; Bo J; Dou LP; Jing Y; Wang SH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):476-8. PubMed ID: 18549611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation of Id4 gene promoter in acute leukemia].
    Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
    Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
    Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of DNA-binding inhibitor 4 promoter methylation status in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Dou LP
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):576-8. PubMed ID: 17074115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
    Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
    Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
    Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study of Aberrant CpG Island Hypermethylation of
    Sun J; Zhang J; Wang Y; Li Y; Zhang R
    Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
    J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
    Vatanmakanian M; Tavallaie M; Ghadami S
    Cell Commun Signal; 2019 Apr; 17(1):38. PubMed ID: 31014357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of methylation status of secreted frizzled-related protein gene promoter in acute leukemia].
    Xu CB; Shen JZ; Shen SF; Fu HY; Zhu YF; Chen L
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):769-71. PubMed ID: 21092449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.